FDA Clears First Drug to Treat Ultra-Rare Metabolic Disorder ...Middle East

Medscape - News
Lumasiran (Oxlumo) is the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder that causes recurrent kidney stones and loss of kidney function. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Clears First Drug to Treat Ultra-Rare Metabolic Disorder )

Apple Storegoogle play

Also on site :